🇮🇳IN
Sign In
MO

MONOPHARMA

NSE

MONO PHARMACARE LIMITED

₹8.50

-0.40(-4.49%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

MONOPHARMA valuation summary

MONO PHARMACARE LIMITED trades at 42.9 times trailing earnings. Return on equity is 1.1% and return on capital employed is 3.5%.

P/E42.9
ROE1.1%
ROCE3.5%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer